Press releaseGlobe Newswire
Orchestra Biomed Holdings
OBIO · NASDAQ
$5.82+$0.17 (+3.01%)TodayMarket closed ·
Prev close $5.65
Latest news
- Press releaseGlobe Newswire
Orchestra BioMed Announces AVIM Therapy to Be Featured in Two Sessions at HRX Live 2026
- NewsAvi Kapoor
Crude Oil Surges 6%; Macy’s Shares Fall After Q2 Results
- NewsAvi Kapoor
Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday
- Press releaseGlobe Newswire
Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates
- Press releaseGlobe Newswire
Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
- News
Orchestra BioMed Plans To Complete Enrollment In Its BACKBEAT Study Of Atrioventricular Interval Modulation Therapy By End Of Q3; Plans To Submit Primary Endpoint Data With Medtronic In Q2
- Press releaseGlobe Newswire
Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027
- Press releaseGlobe Newswire
Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
- Press releaseGlobe Newswire
Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement
- News
Orchestra BioMed Announces Second FDA Breakthrough Device Designation For AVIM Therapy Specific To Patients With Uncontrolled Hypertension Despite Use Of Medications, Along With An Indication For A Pacemaker
- Press releaseGlobe Newswire
FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy
- News
Orchestra BioMed Hldgs Q4 EPS $0.26 Beats $(0.39) Estimate, Sales $30.917M Beat $878.600K Estimate
- News
Assessing Orchestra BioMed Hldgs: Insights From 4 Financial Analysts
- Press releaseBusiness Wire
Vivasure Medical Announces Acquisition by Haemonetics Corporation
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- Press releaseBusiness Wire
Vivasure Medical Submits PMA Application for PerQseal® Elite and Secures Expanded Venous Indication in Europe
- Press releaseBusiness Wire
Vivasure Medical Receives CE Mark Approval in Europe for PerQseal Elite Vascular Closure System
- News
Where Orchestra BioMed Hldgs Stands With Analysts
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Press releaseGlobe Newswire
Orchestra BioMed to Present at Upcoming Investor Conferences
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.